| Pharmacovigilance is a big deal these days. With | | | | Is it user-friendly?It’s great to go in for a |
| companies bringing drugs to the market at the drop | | | | tech-savvy system but keep in mind that the |
| of a hat and regulatory bodies setting up stringent | | | | system must also be user-friendly. Make sure that |
| rules on drug safety standards, an effective | | | | the system is uncomplicated. Your employees must |
| pharmacovigilance system is a necessity for most | | | | be able learn to use the system very quickly and |
| drug manufacturers. | | | | with great ease. |
| Today, regulatory authorities demand greater | | | | Does it streamline case processing?Your |
| transparency during pre-marketing and | | | | pharmacovigilance must make managing and |
| post-marketing of each drug. It’s also imperative | | | | accessing data a whole lot easier. Choose a system |
| that drug companies record and manage data on | | | | that ensures a smooth work flow and streamlines |
| each and every aspect of the drug manufacturing | | | | your processing of individual cases. |
| and marketing process because pharmaceutical risk | | | | Does it offer greater risk management?The core idea |
| management policies are getting tighter by the day. | | | | behind pharmacovigilance is effective and early risk |
| So, it pays to invest in an effective and efficient | | | | management. So, your system must be equipped to |
| pharmacovigilance system as it works to benefit the | | | | monitor, assess and detect drug risks as early as |
| drug manufacturer greatly in the long run. Before | | | | possible in order to avoid huge losses in terms of |
| choosing a pharmacovigilance system, find out if the | | | | finances, manpower, time and patient health in the |
| system answers to these questions favorably. | | | | later stages. |
| Is the pharmacovigilance system technologically | | | | Does it comply with global reporting standards? |
| advanced?Pharmacovigilance involves dealing with | | | | Most drugs are developed for the global market. So, |
| volumes and volumes of data on a day-to-day basis. | | | | your pharmacovigilance system must also adhere to |
| Make sure that the system you are about to invest | | | | global adverse drug event reporting standards or else |
| in is technologically advanced to handle all the | | | | you need to keep investing on different systems for |
| information. Look up for features that make your | | | | different markets. Also, choose a system that |
| work a lot easier. It saves time and improves | | | | complies with the reporting standards of various |
| productivity. You gain a lot in the long haul. | | | | regulatory bodies. |